BSE Live
Nov 07, 14:19Prev. Close
442.10
Open Price
441.95
Bid Price (Qty.)
442.95 (7)
Offer Price (Qty.)
446.90 (3)
NSE Live
Nov 07, 14:19Prev. Close
441.75
Open Price
436.65
Bid Price (Qty.)
443.70 (1)
Offer Price (Qty.)
444.75 (4)
| Cash Flow of Venus Remedies (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 69.16 | 46.65 | 40.33 | 44.67 | 17.62 | |
| Net CashFlow From Operating Activities | 83.10 | 35.38 | 28.05 | 40.90 | 132.67 | |
| Net Cash Used In Investing Activities | -76.20 | -6.94 | -50.81 | -16.65 | 55.65 | |
| Net Cash Used From Financing Activities | 0.00 | 0.00 | 0.00 | -9.13 | -161.88 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 6.90 | 28.44 | -22.76 | 15.12 | 26.45 | |
| Cash And Cash Equivalents Begin of Year | 48.51 | 20.07 | 42.83 | 27.70 | 1.26 | |
| Cash And Cash Equivalents End Of Year | 55.41 | 48.51 | 20.07 | 42.83 | 27.70 |
12.08.2025
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
05.08.2025
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y
28.05.2025
Venus Remedies Standalone March 2025 Net Sales at Rs 194.04 crore, up 10.78% Y-o-Y
05.02.2025
Venus Remedies Standalone December 2024 Net Sales at Rs 172.54 crore, up 31.48% Y-o-Y
12.08.2025
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
05.08.2025
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y
28.05.2025
Venus Remedies Standalone March 2025 Net Sales at Rs 194.04 crore, up 10.78% Y-o-Y
05.02.2025
Venus Remedies Standalone December 2024 Net Sales at Rs 172.54 crore, up 31.48% Y-o-Y